| Age, median (range), y |
7 (0-18) |
8 (0-17) |
| Sex |
|
|
| Male |
32 (47) |
41 (56) |
| Female |
36 (53) |
32 (44) |
| Pathology |
|
|
| Glioma |
24 (35) |
45 (62) |
| Medulloblastoma |
9 (13) |
5 (7) |
| Ependymoma |
9 (13) |
6 (8) |
| Atypical teratoid rhabdoid tumor |
4 (6) |
0 |
| Choroid plexus carcinoma |
5 (7) |
1 (1) |
| Neuroepithelial tumor and pineoblastoma |
3 (4) |
3 (4) |
| Craniopharyngioma and prolactinoma |
3 (4) |
0 |
| Germ cell tumor |
3 (4) |
0 |
| Other |
8 (12) |
13 (18) |
| Tumor location |
|
|
| Frontal lobe |
4 (6) |
12 (16) |
| Optic nerve and chiasm |
19 (28) |
6 (8) |
| Temporal, parietal, and occipital lobes |
7 (10) |
27 (37) |
| Posterior fossa and brainstem |
37 (54) |
28 (38) |
| Other |
1 (2) |
0 |
| 5-y overall survival, mean (SD), % |
78.3 (6.2) |
84.9 (4.7) |
| Follow-up time, median (range), mo |
28 (1-180) |
40 (1-217) |
